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ScienceDirectImmune detection of microbial viability is increasingly
recognized as a potent driver of innate and adaptive immune
responses. Here we describe recent mechanistic insights into
the process of how the immune system discriminates between
viable and non-viable microbial matter. Accumulating
evidence suggests a key role for microbial RNA as a widely
conserved viability associated PAMP (vita-PAMP) and a
molecular signal of increased infectious threat. Toll-like
receptor 8 (TLR8) has recently emerged as a critical sensor for
viable bacteria, ssRNA viruses, and archaea in human antigen
presenting cells (APC). We discuss the role of microbial RNA,
and other potential vita-PAMPs in antimicrobial immunity and
vaccine responses.
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Introduction
“There is nothing over which a free man ponders
less than death; his wisdom is to meditate not on
death but on life”
Erwin Schro¨dinger, ‘What is Life?’
Asked to define ‘life’, each branch of science is likely to
present a different answer. In his collection of lectures
‘What Is Life?’ the Austrian physicist Erwin Schro¨dinger
famously postulated that living organisms are distin-
guished from dead matter by a ‘code-script’, whichCurrent Opinion in Immunology 2019, 56:60–66 enables them to withstand the disturbing forces of disor-
der (entropy) and thereby avoid decay for a period of time
[1]. Pinning down the difference between living and non-
living things remains surprisingly difficult, but several
defining features of ‘life’ are frequently mentioned.
These include the ability to take up energy and transform
it into growth and self-replication. Living organisms
respond to their environment and generally strive to
maintain the order of their internal environment, called
homeostasis. Finally, all known forms of life require
informational molecules, DNA and RNA. Beyond the
borders of these criteria, there is a grey zone of creatures
that lack some defining features of ‘life’, yet they might
still be considered ‘viable’. Viruses, for instance, rely on
other organisms for replication and metabolism and have
been described as living ‘a kind of borrowed life’ [2].
Numerous pathogens have adopted an obligate intracel-
lular ‘lifestyle’ characterized by an inability to grow
outside of their host cells; and dormant life forms, such
as bacterial endospores, are non-reproductive, metaboli-
cally inactive, yet they retain the capacity to revitalize and
reacquire all characteristics of living cells, and most
importantly, they maintain the ability to infect their hosts.
Immune defense systems evolved in response to these
threats from all domains of microbial life and its grey
zones. For the sake of maintaining homeostasis, it appears
that the magnitude and the quality of antimicrobial
immune responses are precisely proportionate to the
infectious threat. Efficient host defense therefore
requires meticulous risk assessment of microbial contacts
[3]. Based on this conceptual framework, we have previ-
ously proposed that the immune system perceives
‘microbial viability’ per se as an indicator of increased
infectious threat [3,4]. Here, we discuss the immune
system’s fundamental capacity to discriminate viable
from non-viable microbial material. We review the most
recent insights into the molecular mechanisms of
‘viability-sensing’ in different species and its effects on
antimicrobial immunity.
Immune recognition beyond ‘self’ versus ‘non-
self’
Pattern recognition arguably forms the basis of ‘self’
versus ‘non-self’ discrimination by the innate immune
system [5]. Pattern recognition receptors (PRRs) detect
conserved molecular patterns (PAMPs) of microorgan-
isms, and PRR activation controls important functions of
antigen presenting cells (APC), with profound effects on
subsequent adaptive immune responses [6]. However,
further distinctions beyond the binary categories of ‘self’www.sciencedirect.com
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infectious threat, in order to elicit an adequately mea-
sured immune response. It has become increasingly clear
that the specific context of PRR engagement and the
nature of their ligands critically shapes the response to a
given microbial encounter. Based on observations that
most pathogens tend to employ common strategies to
cause infection and disease [7], Vance et al. proposed that
the immune system distinguishes disease-causing patho-
gens from less virulent microbes by recognizing such
conserved pathogenic activities as ‘patterns of
pathogenesis’ [4]. Besides cytosolic invasion and active
perturbation of cellular organization, the authors identi-
fied ‘growth’ as a common pathogenic pattern. They
postulated the existence of specific PAMPs that would
convey either bacterial life or death, respectively, to the
immune system. Interestingly, they speculated that the
release of macromolecules such as DNA and RNA would
be indicative of bacterial death [4].
Supporting the idea of designated PAMPs that signify
bacterial cell death, it was recently reported that poly-
meric peptidoglycan (PGN) released from the cell walls
of dying bacteria binds to a regulatory isoform of the
PGN-recognition protein-LC (rPGRP-LC) and inhibits
the immune deficiency (IMD) pathway in Drosophila. In
contrast, monomeric peptidoglycan (PGN), a byproduct
of bacterial growth, activates the IMD pathway leading to
antimicrobial peptide production and inflammation. Bac-
terial lysis, mediated by the secreted antimicrobial pep-
tides, causes the release of polymeric PGN, thus provid-
ing an inhibitory feedback via rPGRP-LC. The study
implies that immune recognition of dead bacteria con-
tributes to the resolution of inflammation in the aftermath
of bacterial infections in flies [8]
Sensing bacterial viability
Epidemiological and empirical data have long suggested
that living microorganisms, such as the ones included in
live attenuated vaccines, induce more robust immune
responses than their killed counterparts in vertebrates [9–
11,12]. Pamer and colleagues noted that vaccination
with heat-killed Listeria moncytogenes failed to prime effec-
tor CD8+ T cells in mice [12], and several other studies
have also reported a superior ability of viable bacteria to
elicit protective immunity [13–15]. Expanding upon
some of these earlier observations, we have recently
uncovered an inherent ability of innate immune cells
to discriminate living from dead bacteria, independently
of their virulence. In murine macrophages and dendritic
cells (DC), detection of live bacteria led to activation of
the NLRP3 inflammasome complex and the subsequent
release of IL-1b, and inflammatory cell death (pyropto-
sis), as well as increased production of type-I Interferon
(IFN) [16]. These unique responses to live bacteria
were dependent on the TLR signaling adaptor molecule
TIR-domain-containing adapter inducing IFN-bwww.sciencedirect.com (TRIF), which suggested a role for pattern recognition
in the detection of living bacteria. While replication
deficient nutritional auxotrophic bacteria (Escherichia
coli), and even paraformaldehyde-inactivated bacteria
induce aforementioned TRIF-mediated responses, bac-
terial killing by heat, antibiotic treatment, or UV irradia-
tion abrogates inflammasome activation [16]. Impor-
tantly, when mixed with living bacteria, heat killed
bacteria do not affect the enhanced responses to living
bacteria. Collectively, these data suggest the existence of
fixable molecules (PAMPs) that associate specifically with
viable bacteria and that elicit distinct immune responses.
Bacterial RNA was identified as such a ‘viability-associ-
ated PAMP’ (vita-PAMP), the detection of which triggers
a state of alert not warranted for dead bacteria [3,16].
Microbial RNA — a versatile signal of
microbial threat
RNA sensors have been extensively studied in the
context of anti-viral defense, with particular focus on
type-I IFN responses initiated by cytosolic helicases
retinoic acid-inducible gene I (RIG-I) and Melanoma
Differentiation-Associated protein 5 (MDA5), or sensors
with direct antiviral activity including protein kinase R
(PKR), 20-50-oligoadenylate synthetase 1 (OAS1), and
ribonuclease L (RNase L) [17]. Several recent publica-
tions have highlighted the hitherto largely overlooked
role of RNA receptors in antibacterial immunity [18].
Bacterial RNA is rapidly released and degraded in dying
bacteria, whereas bacterial DNA is remarkably stable
after bacterial cell death, and can be found in the
remains of tissues even centuries after bacterial infection
[19]. When added together with killed bacteria, bacterial
RNA restores NLRP3 inflammasome activation and
IFN-b production in mouse macrophages and DC to
the same levels elicited by viable bacteria [16]. Human
monocytes and myeloid DC have a similar ability to
discriminate viable from killed bacteria. Detection of
bacterial RNA activates a transcriptional signature, with
selective expression of TNF and Il12B in response to
living bacteria [20] and microbial RNA [21]. Selective
induction of IL-12 is conserved in porcine monocytes
and DC, whereas murine APC produce IL-12 and TNF
in response to a broad variety of inanimate microbial
PAMPs [16,20]. Conversely, IL-1b production is spe-
cifically induced upon detection of viable bacteria and
bacterial RNA in both human and murine APC [16
,20,22]. Interestingly, bacterial spores, although meta-
bolically inactive, also contain high amounts of RNA and
activate inflammatory host responses in humans and
mice, indicating that they are accurately perceived as
infectious threats by the immune system [23]. Detection
of bacterial RNA as a vita-PAMP thus appears to repre-
sent a conserved stimulus for escalated immune
responses, albeit the responses are different in humans
and mice. Sensing of live bacteria and bacterial RNA in
human and porcine APC requires TLR8, a highlyCurrent Opinion in Immunology 2019, 56:60–66
62 Innate immunityconserved endosomal receptor for single-stranded RNA
(ssRNA) [20,] (Figure 1). Despite being expressed in
various cell types, murine TLR8 is irresponsive to
ssRNA [25]. Instead, TLR13 has been shown to sense
bacterial 23S ribosomal RNA in mice [26,27]. Its role in
the recognition of bacterial viability in mice is unclear,
and TLR13 is missing in the human genome [28] (Fig-
ure 1). Its endosomal localization in APC ideally positions
TLR8 to surveil phagocytic cargo for microbial RNA, and
hence signals of microbial viability. Still several questions
regarding the molecular mechanisms of TLR8 activation
by bacterial RNA remain unanswered. The recent resolu-
tion of the molecular structure of TLR8 in complex with its
natural ligand has revealed two distinct ligand interaction
sites that actually bind degradation products of ssRNA,
uridine (U) nucleosides and a U-containing small oligonu-
cleotide, respectively [29]. These new insights pose the
question as to how natural TLR8 ligands are generated
from microbial RNA. This process is likely to involve-
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Current Opinion in Immunology 2019, 56:60–66 (Figure 1), and it will be important to characterize these
enzymes and their potential regulation by other co-factors.
Immune detection of highly conserved molecules like
RNA harbors an inherent hazard of causing self-reactivity
[30]. Activation of TLR8 by self-RNA is prevented on
multiple levels. Ligand accessibility is restricted by segre-
gating TLR8 and endogenous RNA into different subcel-
lular compartments, that is exclusion of RNA from endo-
somes. Availabity of RNA, for example during
efferocytosis, is minimized by rapid degradation of endog-
enous RNA [31,30]. In addition, TLR8 activation by
residual self-RNA is prevented by inhibitory nucleoside
modifications. Mammalian rRNA, for instance, contains
around ten times more pseudoruridines and 25 times more
20-O-methylated nucleosides than bacterial rRNA, which
makes mammalian rRNA generally a very poor TLR8
activator [32]. Mammalian mRNA contains numerous
additional modifications like 5-methylcytidine and N6-
methyladenine, both of which also strongly inhibit
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ifications, with the exception of a 50-nicotinamide adenine
dinucleotide (NAD)-cap structure, found in a subset of
bacterial mRNA transcripts [33]. In addition, TLR8 dis-
plays a certain level of sequence preference for GU-rich
ssRNA [34], whereas 30-polyadenylation appears to inhibit
TLR activation by ssRNA [21]. Inflammasome activation
by bacterial mRNA in mice is also inhibited by
30polyadenylation [16]. Intriguingly, both human and
murine APC respond to prokaryotic mRNA, leading to
NLRP3 inflammasome activation, whereas bacterial
rRNA and small RNAs only activate the inflammasome
in human, but not in murine APC [16,22]. The discrepant
reactogenity of some bacterial RNA species in humans and
mice suggests slightly distinct sensing or transport path-
ways upstream of NLRP3 inflammasome assembly (Fig-
ure 1). So far, the exact mechanisms of NLRP3 activation
in response to bacterial RNA remain incompletely
resolved. In murine APC, it appears that several pathways
collude, involving TRIF-dependent production of IFN-b,
auto-/paracrine induction of Caspase-11 and non-canonical
inflammasome activation (Reference PMC3660860). It
was shown that fractions of phagolysosomal contents trans-
locate to the cytosol during bacterial phagocytosis, yet it is
unclear whether this communication and potential transfer
of bacterial RNA is required for inflammasome activation
(Figure 1)(REF 16). A recent study revealed an unex-
pected TLR8 dependent mode of inflammasome activa-
tion in human monocytes stimulated with the archeon
Methanosphaera stadtmanae, a constituent of the human
microbiome [35]. In fact, all inflammatory responses to
M. stadtmanae were shown to rely on TLR8 and recognition
of archaeal RNA, suggesting that microbial viability might
be critical for immune recognition of archaea, yet this
remains to be investigated. The role of TLR8 for NLRP3
inflammasome activation and IL-1b release in response to
bacteria is currently under investigation (Figure 1). Often
disregarded because of its dysfunction in mice, TLR8 has
lately emerged as one of the most versatile innate immune
sensors of microbial RNA, which is recognized as a con-
served molecular signature of viable bacteria, archaea, and
ssRNA viruses [18,20,34,35].
Metabolic responses to bacterial RNA
Microbial infections cause profound metabolic repro-
gramming of innate immune cells, in order to promote
inflammation and pathogen clearance, and eventually
restoration of tissue homeostasis [36,37]. Macrophages
exposed to LPS or killed bacteria undergo a glycolytic
switch, characterized by decreased mitochondrial respira-
tion and enhanced glycolysis. Interestingly, recognition of
live bacteria and bacterial RNA induces rapid modula-
tions of the mitochondrial electron transport chain
(ETC). Whereas both live and killed bacteria induce a
lower ETC complex I (CI) activity, only live bacteria
evoke a concomitantly increased activity of CII and as a
result, the accumulation of fumarate, an intermediate inwww.sciencedirect.com the tricarboxylic acid cycle with antimicrobial and immu-
nomodulatory activities [38]. The observed mitochon-
drial ETC adaptations required TLR-induced reactive
oxygen species (ROS), generated by the phagosomal
NAPDH oxidase 2 (NOX2). Increased electron flow from
CII promotes mitochondrial ROS formation and inflam-
matory immune responses, including NLRP3 inflamma-
some activation [39] (Figure 1). Blocking CII activity
during phagocytosis of live bacteria reverses inflammatory
cytokine production [38]. These findings establish a
link between the recognition of bacterial RNA, mitochon-
drial respiration, and inflammatory cytokine production.
Other vita-PAMPs
Other molecular signatures of microbial viability (=vita-
PAMPs) besides RNA, are likely to exist. Possible can-
didates include byproducts of bacterial metabolites and
signaling molecules like second-messengers, signal pep-
tides [40] and quorum sensing molecules [41]. It was
recently reported that cyclic-di-adenosine monopho-
sphate (c-di-AMP), a second messenger molecule in
Gram-positive bacteria, is recognized as a vita-PAMP
in murine macrophages [42]. It has been noted earlier
that c-di-AMP directly binds and activates Stimulator of
IFN genes (STING) [43], a sensor of endogenous cyclic
di-nucleotide cGMP–cAMP (cGAMP) produced in
response to cytosolic DNA [44]. Located on the endo-
plasmic reticulum, STING activation induces ER mem-
brane stress. This triggers mTOR inactivation and
enhanced autophagy of damaged ER membranes, some-
times referred to as ER-phagy [45]. Removal of damaged
ER prevents cell death and additionally orchestrates an
IFN response by redistributing ER-resident STING to
autophagosomal membranes [42,46] (Figure 1). The con-
tribution of listeriolysin-O (LLO, encoded by Hly)-medi-
ated cytosolic invasion and release of c-di-AMP for
STING activation is not fully understood. Hly-deficient
Listeria monocytogenes mutants, although fully viable,
failed to activate STING and IFN responses upon injec-
tion into mice [47]. In contrast, non-invasive L.innocua
were shown to activate STING, autophagy, and IFN
responses in macrophages and DC, as long as the bacteria
were viable [42]. Thus, it remains to be further investi-
gated whether bacterial cyclic di-nucleotides generally
function as vita-PAMPs, especially in human phagocytes
(Figure 1).
Impact of vita-PAMPs on immunity
Detection of microbial viability has effects beyond clas-
sical APC like monocytes, macrophages and DC. Recog-
nition of live bacteria or bacterial RNA induces enhanced
NETosis [48], a highly inflammatory form of cell death in
neutrophils that is characterized by the expulsion of
nuclear DNA and proteins, so called neutrophil-extracel-
lular traps (NETs) [49]. Limiting highly inflammatory
and damaging responses like NETosis to encounters of
acute infectious threat may be required for tissueCurrent Opinion in Immunology 2019, 56:60–66
64 Innate immunityhomeostasis, although many microbial triggers of NETo-
sis have been described [49].
Besides cells of the innate immune system, there are T
cells that specialize in detecting viable microorganisms.
Mucosal associated invariant T cells (MAIT cells), a large
population of semi-invariant T cells, respond to live but
not to killed bacteria [50]. MAIT cells recognize an
intermediate in the microbial biosynthesis of riboflavin
(vitamin B2) as their cognate antigen, which is not found
in dead microbes or in host cells [51].
Conventional T cell and B cell responses are also regu-
lated following innate immune recognition of microbial
viability. Activation of TLR8 in human APC by live
bacteria, bacterial RNA, or nucleoside analogues is a
potent driver of T follicular helper (TFH) cell differenti-
ation and vaccine responses [20]. TFH cells represent a
specialized T helper cell subset with a critical role in
germinal center reactions, B cell memory, and humoral
immunity. Vaccination with live bacteria enhances the
generation of TFH cells and humoral immune responses
in swine and in mice [20,24]. Moreover, a hypermorphic
TLR8 single-nucleotide polymorphism is associated with
improved protective immunity elicited by vaccination
with a live bacterial vaccine, bacillus Calmette-Gue´rin
(BCG), in a human cohort [20]. These new findings may
help to explain the often-observed superiority of live
attenuated vaccines at inducing long-lived protective
immunity.
Finally, TLR8 seems to play a unique role in neonatal
immunity. Neonatal phagocytes display a profound
hyporesponsiveness to most microbial stimuli — except
for TLR8 ligands [52]. Agonists of TLR8 can significantly
boost otherwise notoriously blunted neonatal vaccine
responses [53]. Restricting inflammatory immune
responses to a minimum might be advantageous in early
life, in order to permit colonization of body surfaces by
beneficial microflora, while reducing the risk of invasive
infection via surveillance of the cell interior for traces of
microbial life.
Concluding remarks
Immune detection of microbial viability is increasingly
recognized as a potent driver of innate and adaptive
immune responses. Here we describe recent mechanistic
insights into this process. Accumulating evidence sug-
gests a key role for microbial RNA as a widely conserved
vita-PAMP and a molecular signal of increased infectious
threat. TLR8 has been identified as an important sensor
for viable bacteria, archaea, and certain viruses, but fur-
ther clarification of the cellular recognition pathways and
their impact on antimicrobial immunity is needed. Most
of the studies presented in this review dissected antibac-
terial responses, and it will be important to expand the
current findings to other relevant microbes, especiallyCurrent Opinion in Immunology 2019, 56:60–66 those included in common ‘live attenuated’ vaccines.
Despite recent advances, the concept of ‘viability-
recognition’ will clearly require further experimental
exploration. Some of our current views may need to be
revised in the future, which takes us back to Schro¨dinger
and ‘What is Life?’: “If a man never contradicts himself, the
reason must be that he virtually never says anything at all.”
(Erwin Schro¨dinger)
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